Bial - Portela C S.a.
Clinical trials sponsored by Bial - Portela C S.a., explained in plain language.
-
New drug opicapone tested for Parkinson's motor symptoms in italian study
Disease control Recruiting nowThis study looks at how well and how safely the drug opicapone works for people with Parkinson's disease who have early motor fluctuations (uncontrolled movements). About 200 adults aged 30 and older in Italy will take part. Researchers will check if symptoms improve after 12 mon…
Sponsor: Bial - Portela C S.A. • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
New study aims to Fine-Tune Parkinson's rescue treatment
Symptom relief Recruiting nowThis study is for people with Parkinson's disease who experience OFF episodes—times when symptoms return between medication doses. It will track how patients use SL-APO, a fast-acting treatment, to find the best dosing approach. The goal is to improve patient satisfaction and bal…
Sponsor: Bial - Portela C S.A. • Aim: Symptom relief
Last updated May 26, 2026 04:30 UTC